---
layout: post
title: 'USAN Watch: December 2012'
date: '2012-12-13T20:43:00.001Z'
author: John Overington
tags:
- INNS and USANS
modified_time: '2013-01-02T09:10:10.988Z'
thumbnail: http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-6365697829302611011
blogger_orig_url: http://chembl.blogspot.com/2012/12/usan-watch-december-2012.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png"><img border="0" src="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" /></a></div>
<span class="Apple-style-span" style="font-family: inherit;">The USANs for December 2012 have recently been published.</span><br />
<br />
<table border="1"><tbody>
<tr><td><b><span class="Apple-style-span" style="font-family: inherit;">USAN </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Research Code </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Structure</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Drug Class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Therapeutic class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Target</span></b></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/dalantercept.pdf">delantercept</a></td><td>ACE-041</td><td><br /></td><td>immunoadhesin</td><td>therapeutic</td><td>TGFbeta</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/imilecleucel-t.pdf">imilecleucel-t</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<br />
<br />
<table border="1"><tbody>
</tbody></table>
</div>
</div>
</div>
</td><td><br /></td><td>cellular immunotherapy</td><td>therapeutic</td><td>n/a</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/palifosfamide-tromethamine.pdf">palifosfamide tromethamine</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">ZIO-201T&nbsp;</span></span></div>
</div>
</div>
</td><td><div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-prXoK2_o6WM/UMo9t-Tzq3I/AAAAAAAACeo/nzAYVUHVwnY/s1600/pali.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-prXoK2_o6WM/UMo9t-Tzq3I/AAAAAAAACeo/nzAYVUHVwnY/s1600/pali.png" /></a></div>
<br /></td><td>synthetic small molecule</td><td>therapeutic</td><td>n/a</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/regorafenib.pdf">regorafenib</a></td><td><br />
<div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-family: inherit;">BAY-73-4506&nbsp;</span></div>
</div>
</div>
</td><td><a href="http://1.bp.blogspot.com/-Mu6411Q8-FA/UMo9xiAFmhI/AAAAAAAACew/MmzKjOR3tns/s1600/rego.png" imageanchor="1"><img border="0" src="http://1.bp.blogspot.com/-Mu6411Q8-FA/UMo9xiAFmhI/AAAAAAAACew/MmzKjOR3tns/s1600/rego.png" /></a></td><td>synthetic small molecule</td><td>therapeutic</td><td>VEGFR2 TIE2</td></tr>
</tbody></table>
<br /><div>
jpo</div>
